You’re offline. This is a read only version of the page.
Newborn Screening identifies conditions that can affect a child's long-term health or survival. CDC's Newborn Screening and Molecular Biology Branch manages the Newborn Screening Quality Assurance Program (NSQAP) to enhance and maintain the quality and accuracy of newborn screening results. The program provides training, consultation, guidelines, and dried blood spot proficiency testing and quality control materials to state public health laboratories and other laboratories responsible for newborn screening in the U.S. and many other countries.
NSQAP at A Glance
A2LA Accredited PT Provider
CDC’s Newborn Screening and Molecular Biology Branch (NSMBB) is accredited by the American Association for Laboratory Accreditation (A2LA) to ISO/IEC 17043 for proficiency testing. NSMBB was the first CDC program to achieve ISO 17043 accreditation in 2017. In addition, NSMBB’s Newborn Screening Quality Assurance Program (NSQAP) became the first CDC program to be accredited to the ISO 17034 standard in 2023, which recognizes competence in the production of reference materials used for quality assurance and calibration. For a complete list of accredited NSMBB quality assurance and proficiency testing programs, please refer to A2LA Certificates 4190.01 and 4190.02: https://customer.a2la.org/index.cfm?event=directory.detail&labPID=7A93608C-FE77-49A1-AA25-9014123C4F09
Request Participation
If you are interested in participating in NSQAP, please complete the Participant Request Form. Approved participants will receive materials according to the annual distribution schedule. All products and shipping are provided at no cost to participating laboratories; however, laboratories are responsible for any required documentation, import fees, taxes, and other associated costs. Participants must submit data for each requested product at least once per year to remain enrolled in the program.
NSQAP Public Reports
If you would like to access previously published reports, please click here.
